An international team of researchers led by Dalhousie immunologists and critical care specialists in Spain has found key biomarkers in the plasma of COVID-19 patients, which will help predict the severity of illness and could lead to new treatments for the virus.
The findings, published Tuesday in the journal Critical Care, involved 250 patients with COVID-19 whose plasma was tested in Spain for the presence of ribonucleic acid or RNA, the viruss genetic blueprint….